- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Schizophrenia
- Meeting Date: July 2025
- Public Summary Document (PSD) July 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) July 2025 PBAC Meeting - (Word)
Paliperidone – July 2025
Paliperidone; I.M. injection (modified release) 25 mg (as palmitate) in pre-filled syringe, I.M. injection (modified release) 50 mg (as palmitate) in pre-filled syringe, I.M. injection (modified release) 75 mg (as palmitate) in pre-filled syringe, I.M. injection (modified release) 100 mg (as palmitate) in pre-filled syringe, I.M. injection (modified release) 150 mg (as palmitate) in pre-filled syringe; Paljuna Monthly
Last updated
9 July 2025
